ASTM F1441-03
(Specification)Standard Specification for Soft-Tissue Expander Devices
Standard Specification for Soft-Tissue Expander Devices
ABSTRACT
This specification covers the requirements for single use saline inflatable, smooth and textured tissue expansion devices to be used intraoperatively or implanted for typically less than 6 months and then removed. This specification applies only to soft-tissue expander devices fabricated with elastomer shells. It does not necessarily cover any custom fabricated soft tissue expander device manufactured to any other specification. The device shall be classified as: Type I; Type II; and Type III. Biocompatibility, tensile set, breaking force, tubing shell junction, injection port competence, overexpansion, tubing length adapter strength, needle stop penetration, and fused or adhered joints tests shall be performed to conform with the specified requirements.
SCOPE
1.1 This specification covers the requirements for single use saline inflatable, smooth and textured tissue expansion devices to be used intraoperatively or implanted for typically less than 6 months and then removed.
1.2 Limitations:
1.2.1 This specification applies only to soft-tissue expander devices fabricated with elastomer shells. It does not necessarily cover any custom fabricated soft tissue expander device manufactured to any other specification.
1.2.2 This specification applies, in part, to combination "expander/mammary" devices as classified in Section 4.
1.3 The values stated in SI units are to be regarded as standard, values in parentheses are for information only.
1.4 The following statement pertains only to the test methods and requirements portion, Section 9, of this specification. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
General Information
Relations
Standards Content (Sample)
NOTICE: This standard has either been superseded and replaced by a new version or withdrawn.
Contact ASTM International (www.astm.org) for the latest information
Designation: F 1441 – 03
Standard Specification for
1
Soft-Tissue Expander Devices
This standard is issued under the fixed designation F 1441; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (e) indicates an editorial change since the last revision or reapproval.
1. Scope Used in Medical Applications Part I—Formulations and
3
Uncured Materials
1.1 This specification covers the requirements for single use
F 2042 Guide for Silicone Elastomers, Gels, and Foams
saline inflatable, smooth and textured tissue expansion devices
Used in Medical Application Part II—Crosslinking and
to be used intraoperatively or implanted for typically less than
3
Fabrication
6 months and then removed.
F 2051 Specification for Implantable Saline Filled Breast
1.2 Limitations:
3
Prosthesis
1.2.1 This specification applies only to soft-tissue expander
2.2 Other Documents:
devicesfabricatedwithelastomershells.Itdoesnotnecessarily
4
Federal Register, Title 21, Part 820
cover any custom fabricated soft tissue expander device
5
USP (United States Pharmacopoeia)
manufactured to any other specification.
Association for the Advance of Medical Instrumentation:
1.2.2 This specification applies, in part, to combination
ANSI/AAMI/ISO 10993-1, Biological Testing of Medical
“expander/mammary” devices as classified in Section 4.
and Dental Materials and Devices—Part 1: Guidance on
1.3 The values stated in SI units are to be regarded as
6
Selection of Tests
standard, values in parentheses are for information only.
ANSI/AAMI/ST50-1995, Dry Heat (Heated Air) Steriliz-
1.4 The following statement pertains only to the test meth-
6
ers
ods and requirements portion, Section 9, of this specification.
ANSI/AAMI/ISO 11135-1994, Medical Devices—
This standard does not purport to address all of the safety
Validation and Routine Control of Ethylene Oxide Steril-
concerns, if any, associated with its use. It is the responsibility
6
ization
of the user of this standard to establish appropriate safety and
ANSI/AAMI/ISO 11137-1994, Sterilization of Health Care
health practices and determine the applicability of regulatory
Products—Requirements for Validation and Routine and
limitations prior to use.
6
Routine Control—Radiation Sterilization
2. Referenced Documents ANSI/AAMI/ISO 11134-1993, Sterilization of Health Care
Products—Requirements for Validation and Routine
2.1 ASTM Standards:
6
Control—Industrial Moist Heat Sterilization
D 412 Test Methods for Vulcanized Rubber and Thermo-
2
Parenteral Drug Association, 1981 Technical Report No. 3,
plastic Elastomers—Tension
Validation of Dry Heat Processes Used for Sterilization
D 624 Test Method for Tear Strength of Conventional
7
2
and Depyrogenation
Vulcanized Rubber and Thermoplastic Elastomers
D 1349 Practice for Rubber—Standard Temperatures for
3. Terminology
2
Testing
3
3.1 Definitions:
F 703 Specification for Implantable Breast Prostheses
3.1.1 injection port—the port through which an injection to
F 748 Practice for Selecting Generic Biological Test Meth-
3
inflate or deflate the variable volume device is made.
ods for Materials and Devices
3.1.1.1 remote port—aportthatisremotefromtheshelland
F 1251 Terminology Relating to Polymeric Biomaterials in
3
attached to the shell by means of tubing.
Medical and Surgical Devices
F 2038 Guide for Silicone Elastomers, Gels and Foams
4
AvailablefromU.S.GovernmentPrintingOfficeSuperintendentofDocuments,
732 N. Capitol St., NW, Mail Stop: SDE, Washington, DC 20401.
1 5
This specification is under the jurisdiction of ASTM Committee F04 on United States Pharmacopeia, Vol XXI, Mack Publishing Company, Easton, PA
Medical and Surgical Materials and Devices and is the direct responsibility of 1989. Available from Pharmacopeia Convention, Inc., 12601 Twinbrook Parkway,
Subcommittee F04.32 on Plastic and Reconstructive Surgery. Rockville, NC 00852.
6
Current edition approved Apr. 10, 2003. Published May 2003. Originally Available fromAmerican National Standards Institute (ANSI), 25 W. 43rd St.,
approved in 1992. Last previous edition approved in 2002 as F 1441 – 92 (2002). 4th Floor, New York, NY 10036.
2 7
Annual Book of ASTM Standards, Vol 09.01. Available from the Parenteral Drug Association, 3 Bethesda Medical Center,
3
Annual Book of ASTM Standards, Vol 13.01. Suite 1500, Bethesda, MD 20814.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959, United States.
1
---------------------- Page: 1 ----------------------
F1441–03
3.1.1.2 self-contained (integrated) port—a port that is inte- reasonable safety and efficacy as it relates to the biocompat-
gral to the device shell. ibility and the mechanical integrit
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.